Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.3%

163 terminated/withdrawn out of 1327 trials

Success Rate

84.3%

-2.2% vs industry average

Late-Stage Pipeline

126 trials in Phase 3/4

Results Transparency

39%

341 of 872 completed trials have results

Key Signals

164 recruiting341 with results115 terminated48 withdrawn

Enrollment Performance

Analytics

N/A

582(56.9%)

Phase 2

170(16.6%)

Phase 1

116(11.4%)

Phase 4

94(9.2%)

Phase 3

32(3.1%)

Early Phase 1

28(2.7%)

1022Total

N/A(582)

Phase 2(170)

Phase 1(116)

Phase 4(94)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1327)

Showing 20 of 1327 trials

NCT06975046Not ApplicableRecruiting

Aerodynamic Measurements in the Pediatric Population

Role: lead

NCT07271940Not ApplicableActive Not Recruiting

Full Plate Living Nutrition Education Program

Role: lead

NCT07456241Not ApplicableNot Yet Recruiting

Ambient AI for Reducing Nursing Staff Documentation Time

Role: lead

NCT06051474Phase 4Completed

Treating Caregivers Who Smoke at AFCH

Role: lead

NCT06581250Not ApplicableActive Not Recruiting

Improving Show Rates in Dental Care Settings Serving Underserved Populations

Role: lead

NCT07173049Not ApplicableNot Yet Recruiting

Speech Production Enhancement Using Augmentative Communication for Kids

Role: lead

NCT07532083Recruiting

Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery

Role: lead

NCT05373017Not ApplicableRecruiting

Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors

Role: lead

NCT07440004Phase 1Recruiting

Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts

Role: lead

NCT07472322Phase 1Not Yet Recruiting

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Role: lead

NCT05609435Not ApplicableCompleted

Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer

Role: lead

NCT02190253Completed

Seroprevalence of Hepatitis E in People With an Organ Transplant

Role: collaborator

NCT06305624Not ApplicableRecruiting

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

Role: lead

NCT06495710Not ApplicableRecruiting

Arterial Stiffness and Blood Pressure

Role: collaborator

NCT07451197Not ApplicableNot Yet Recruiting

Family-Focused Study to Support Medication for Opioid Use Disorder

Role: lead

NCT07523191Not ApplicableRecruiting

Validation of Presence-IP1.0 for Detection of Consciousness Using Reduced-Montage TMS-EEG

Role: lead

NCT03023202Recruiting

UWCCC Molecular Tumor Board Registry

Role: lead

NCT05593523Active Not Recruiting

Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes

Role: lead

NCT03769298Phase 2Recruiting

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

Role: lead

NCT06474299Phase 4Recruiting

The Avenues Study: Dual Use Cessation

Role: lead